Assembly Biosciences, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
Assembly Biosciences, Inc. (ASMB) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $51.18 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-11-08
- 2018-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $51.18M.
- 2018-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $32.22M.
- 2018-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $36.41M.
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $36.83M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2018-09-30 | $51.18M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $32.22M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $36.41M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $36.83M 10-K · filed 2018-03-08 |
| 2017-09-30 | $33.12M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $33.44M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $13.84M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $20.56M 10-K · filed 2017-03-02 |
| 2016-09-30 | $36.47M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $43.46M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |